Nifty200 Alpha30 Corporate Filings & Announcements

Latest corporate announcements and filings from Nifty200 Alpha30 on BSE

Load latest

Solar Industries India Ltd.

12 May 2025

14720.00

3.72%

Board Meeting

Solar Industries India Ltd - 532725 - Board Meeting Intimation for The Meeting Of Board Of …

BSE India

Solar Industries India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2025 ,inter alia, to consider and approve the Audited Standalone & Consolidated Financial Results of the Company for the quarter and year ended on March 31, 2025; and to consider and recommend a final Dividend, if any, for the financial year ended March 31, 2025.

pdf

CG Power and Industrial Solutions Ltd.

12 May 2025

692.00

-0.29%

Company Update

CG Power and Industrial Solutions Ltd - 500093 - Announcement under Regulation 30 (LODR)-Analyst / Investor …

BSE India

Please find enclosed the link of the transcript of the earrings call held on 6th May 2025.

pdf

Glenmark Pharmaceuticals Ltd.

12 May 2025

1428.40

-0.81%

SAST

Glenmark Pharmaceuticals Ltd - 532296 - Closure of Trading Window

BSE India

The trading window has been closed from March 31, 2025 to May 25, 2025 (both days inclusive) for the purpose of approval of Audited Financial Results for the quarter and year ended March 31, 2025.

pdf

Hindalco Industries Ltd.

12 May 2025

643.15

-2.99%

Investor Presentation

Hindalco Industries Ltd - 500440 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Please find enclosed herewith Investor Presentation of Novelis Inc. for Q4FY25 and financial year ended March 31, 2025

pdf

Hindalco Industries Ltd.

12 May 2025

643.15

-2.99%

Company Update

Hindalco Industries Ltd - 500440 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Please find enclosed herewith the Press Release of Novelis Inc. for Q4FY25 and financial year ended March 31, 2025.

pdf

Glenmark Pharmaceuticals Ltd.

12 May 2025

1428.40

-0.81%

Board Meeting

Glenmark Pharmaceuticals Ltd - 532296 - Board Meeting Intimation for Considering And Approving The Standalone And …

BSE India

Glenmark Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2025 ,inter alia, to consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and year ended March 31, 2025 and to consider and recommend dividend, if any, on Equity shares for the year ended March 31, 2025.

pdf